These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 25109331)

  • 1. Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity.
    Riemer P; Sreekumar A; Reinke S; Rad R; Schäfer R; Sers C; Bläker H; Herrmann BG; Morkel M
    Oncogene; 2015 Jun; 34(24):3164-75. PubMed ID: 25109331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
    Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
    Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.
    Lee G; Goretsky T; Managlia E; Dirisina R; Singh AP; Brown JB; May R; Yang GY; Ragheb JW; Evers BM; Weber CR; Turner JR; He XC; Katzman RB; Li L; Barrett TA
    Gastroenterology; 2010 Sep; 139(3):869-81, 881.e1-9. PubMed ID: 20580720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.
    Juan J; Muraguchi T; Iezza G; Sears RC; McMahon M
    Genes Dev; 2014 Mar; 28(6):561-75. PubMed ID: 24589553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt and BMP signals control intestinal adenoma cell fates.
    Farrall AL; Riemer P; Leushacke M; Sreekumar A; Grimm C; Herrmann BG; Morkel M
    Int J Cancer; 2012 Nov; 131(10):2242-52. PubMed ID: 22344573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis.
    Leach JDG; Vlahov N; Tsantoulis P; Ridgway RA; Flanagan DJ; Gilroy K; Sphyris N; Vázquez EG; Vincent DF; Faller WJ; Hodder MC; Raven A; Fey S; Najumudeen AK; Strathdee D; Nixon C; Hughes M; Clark W; Shaw R; ; van Hooff SR; Huels DJ; Medema JP; Barry ST; Frame MC; Unciti-Broceta A; Leedham SJ; Inman GJ; Jackstadt R; Thompson BJ; Campbell AD; Tejpar S; Sansom OJ
    Nat Commun; 2021 Jun; 12(1):3464. PubMed ID: 34103493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium.
    Brandt R; Sell T; Lüthen M; Uhlitz F; Klinger B; Riemer P; Giesecke-Thiel C; Schulze S; El-Shimy IA; Kunkel D; Fauler B; Mielke T; Mages N; Herrmann BG; Sers C; Blüthgen N; Morkel M
    Nat Commun; 2019 Jul; 10(1):2919. PubMed ID: 31266962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.
    Sakamaki A; Katsuragi Y; Otsuka K; Tomita M; Obata M; Iwasaki T; Abe M; Sato T; Ochiai M; Sakuraba Y; Aoyagi Y; Gondo Y; Sakimura K; Nakagama H; Mishima Y; Kominami R
    Carcinogenesis; 2015 Jun; 36(6):622-31. PubMed ID: 25827435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells.
    Kabiri Z; Greicius G; Zaribafzadeh H; Hemmerich A; Counter CM; Virshup DM
    J Clin Invest; 2018 Aug; 128(9):3806-3812. PubMed ID: 30059017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Injury Damages Intestinal Stem Cells.
    Lu R; Voigt RM; Zhang Y; Kato I; Xia Y; Forsyth CB; Keshavarzian A; Sun J
    Alcohol Clin Exp Res; 2017 Apr; 41(4):727-734. PubMed ID: 28195397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt Signaling Inhibition Deprives Small Intestinal Stem Cells of Clonogenic Capacity.
    Janeckova L; Fafilek B; Krausova M; Horazna M; Vojtechova M; Alberich-Jorda M; Sloncova E; Galuskova K; Sedlacek R; Anderova M; Korinek V
    Genesis; 2016 Mar; 54(3):101-14. PubMed ID: 26864984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.
    Bond CE; Liu C; Kawamata F; McKeone DM; Fernando W; Jamieson S; Pearson SA; Kane A; Woods SL; Lannagan TRM; Somashekar R; Lee Y; Dumenil T; Hartel G; Spring KJ; Borowsky J; Fennell L; Bettington M; Lee J; Worthley DL; Leggett BA; Whitehall VLJ
    Epigenetics; 2018; 13(1):40-48. PubMed ID: 29235923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bmi1 regulates murine intestinal stem cell proliferation and self-renewal downstream of Notch.
    López-Arribillaga E; Rodilla V; Pellegrinet L; Guiu J; Iglesias M; Roman AC; Gutarra S; González S; Muñoz-Cánoves P; Fernández-Salguero P; Radtke F; Bigas A; Espinosa L
    Development; 2015 Jan; 142(1):41-50. PubMed ID: 25480918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer.
    Tong K; Pellón-Cárdenas O; Sirihorachai VR; Warder BN; Kothari OA; Perekatt AO; Fokas EE; Fullem RL; Zhou A; Thackray JK; Tran H; Zhang L; Xing J; Verzi MP
    Cell Rep; 2017 Dec; 21(13):3833-3845. PubMed ID: 29281831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
    Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
    Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
    Fang L; Zhu Q; Neuenschwander M; Specker E; Wulf-Goldenberg A; Weis WI; von Kries JP; Birchmeier W
    Cancer Res; 2016 Feb; 76(4):891-901. PubMed ID: 26645562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.